News
Replimune Group Presented The Interim Results From The ARTACUS Clinical Trial Of RP1 Monotherapy In Solid Organ And Hematopoietic Cell Transplant Recipients With Skin Cancers At AACR 2024
8 Apr 24
News
Replimune Group: Q3 Earnings Insights
8 Feb 24
Earnings
Replimune Group Q3 EPS $(0.77) Beats $(0.93) Estimate
8 Feb 24
Earnings, Earnings Beats, News
Press releases
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
7 Apr 24
Health Care, Press Releases
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 Apr 24
Press Releases
Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
26 Mar 24
News, Management, Press Releases
Replimune to Present at the American Association for Cancer Research Annual Meeting 2024
6 Mar 24
News, Health Care, Press Releases
Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
8 Feb 24
Earnings, Press Releases